Correct.
Where it rings a bell with me is we now know the rift between the CEO and former board resulted in the CEO believing they wanted to pursue a strategy that was not in his view in the best interests of the share holders.
Sit back and imagine the pressure that would be applied, if for example PAA sold the canine treatment and it was retailed for say $10,000.00 for a years treatment. [Which I think would eclipse what most could afford to spend on a pet] Then MPL was released for $150,000 PA to treat ALS. Every politician looking for TV time would be milking it as much as they could with their Faux concern.
Cheers
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-255
-
- There are more pages in this discussion • 380 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.010(4.88%) |
Mkt cap ! $77.20M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.8¢ | $342.8K | 1.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52999 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 421000 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |